21 C.F.R. § 862.1465

Lipase test system.

Last amended: 2016Year: 2026Length: 86 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 862.1465 (2026)

(a) Identification. A lipase test system is a device intended to measure the activity of the enzymes lipase in serum. Lipase measurements are used in diagnosis and treatment of diseases of the pancreas such as acute pancreatitis and obstruction of the pancreatic duct. (b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9. [52 FR 16122, May 1, 1987, as amended at 65 FR 2307, Jan. 14, 2000]
Cross-references to the CFR
862.9.
21 C.F.R. § 862.1465: Lipase test system. | Justis AI